Morphine-Tolerant Mice Exhibit a Profound and Persistent Cardioprotective Phenotype
- 16 March 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (10) , 1219-1222
- https://doi.org/10.1161/01.cir.0000121422.85989.bd
Abstract
Background— Morphine and other opioids continue to be used as the major treatment for acute pain both before and after surgery. In this regard, much research has focused on the mechanisms of morphine tolerance and dependence in the central nervous system; however, few studies have examined the effect of morphine on peripheral organs, such as the heart, in morphine-tolerant animals. Here, we examine the effect of tolerance to the analgesic effect of morphine on ischemic tolerance in mice after prolonged morphine exposure and withdrawal. Methods and Results— Male C57/BL6 mice were implanted subcutaneously with either placebo or morphine pellets (25 or 75 mg). After prolonged exposure to and/or withdrawal from morphine or placebo, the hearts were excised and subjected to 25 minutes of ischemia and 45 minutes of reperfusion. Morphine-tolerant mice exhibited a markedly improved functional recovery compared with placebo and mice subjected to acute morphine. Lactate dehydrogenase release was also significantly reduced. The protection observed was equieffective 48 hours after withdrawal of pellet, whereas the onset of protection preceded analgesic tolerance. Conclusions— These data demonstrate that chronic exposure to morphine unexpectedly results in a profound and persistent cardioprotective phenotype.Keywords
This publication has 15 references indexed in Scilit:
- Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatmentLife Sciences, 2003
- Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosineAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- The role of spinal neuropeptides and prostaglandins in opioid physical dependenceBritish Journal of Pharmacology, 2002
- Opioids and cardioprotectionPharmacology & Therapeutics, 2001
- Prolonging the Delayed Phase of Myocardial Protection: Repetitive Adenosine A1Receptor Activation Maintains Rabbit Myocardium in a Preconditioned State 11Dr. Dana is supported by a Junior Research Fellowship, and Dr. Baxter by an Intermediate Fellowship, from the British Heart Foundation, London. Continuing support (Drs. Dana and Baxter) is provided by the Hatter Foundation, London.Journal of the American College of Cardiology, 1998
- The Anti-infarct Effect of an Adenosine A1-Selective Agonist is Diminished After Prolonged Infusion as is the Cardioprotective Effect of Ischaemic Preconditioning in Rabbit HeartJournal of Molecular and Cellular Cardiology, 1994
- After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 gangliosideBrain Research, 1992
- Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents.Proceedings of the National Academy of Sciences, 1990
- Morphine-induced immunomodulation is not related to serum morphine concentrationsEuropean Journal of Pharmacology, 1988
- Mu and delta receptors belong to a family of receptors that are coupled to potassium channels.Proceedings of the National Academy of Sciences, 1987